Clinical Trial Update: TEAM (Thiotepa, Etoposide, Cytosar, Melphalan ) for AutoSCT in Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the TEAM conditioning regimen (thiotepa, etoposide, cytarabine (Cytosar), melphalan) for autologous stem cell transplantatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Drugs mentioned

• Cytosar (cytarabine)
• Etoposide (Etoposide)
• Melphalan (Melphalan)
• THIOTEPA (THIOTEPA)

Snippet

Sponsor: Sheba Medical Center | Conditions: Malignant Lymphoma | Phase 2 | Status: COMPLETED